Home › Juvenile Arthritis › Oregon › Portland
Juvenile Arthritis clinical trials in Portland, OR
5 studies for Juvenile Arthritis are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
RecruitingPhase 1
- Legacy Emanuel Research Hosp Portland, Portland
A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
RecruitingPhase 2
- Legacy Emanuel Research Hosp Portland, Portland
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
RecruitingPhase 3
- Randall Children's Hospital /ID# 251829, Portland
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RecruitingObservational study
- Randall Children's Hospital at Legacy Emanuel, Portland
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
RecruitingObservational studyHealthy volunteers welcome
- Casey Eye Institute - Oregon Health & Science University, Portland
About Juvenile Arthritis
Juvenile arthritis or JA, causes joint swelling, pain, stiffness and loss of motion in children. Learn diagnosis and tests for JA.
More about Juvenile Arthritis on MedlinePlus
Juvenile Arthritis trials in other cities
- Cincinnati, OH6 studies
- Washington, DC6 studies
- Pittsburgh, PA4 studies
- Salt Lake City, UT4 studies
- New York City, NY4 studies
- Cleveland, OH3 studies
- Gainesville, FL3 studies
- Indianapolis, IN3 studies
Other studies in Portland
- Non-Small Cell Lung Cancer45 studies
- Cancer (all types)35 studies
- Prostate Cancer33 studies
- Breast Cancer32 studies
- Metastatic Cancer30 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
- Acute Myeloid Leukemia25 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.